Impact of New Chemotherapeutic and Targeted Agents on Survival in Stage IV Non-Small Cell Lung Cancer

PURPOSE. Significant advances in the systemic management of metastatic non-small cell lung cancer (NSCLC) have occurred over the past decade, with options now including multiple lines of chemotherapy, epidermal growth factor receptor inhibitors, and antiangiogenic agents. Improvements in overall sur...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yu, Joanne L., Simmons, Christine, Victor, J. Charles, Han, Dolly, Hogeveen, Sophie, Leighl, Natasha, Verma, Sunil
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2011
Matèries:
Lung Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228167/
https://ncbi.nlm.nih.gov/pubmed/21835896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0079
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars